Clinical Trials on Confirm PCA-9000A PET/CT System is Effective for Its Intended Use
Total 1 results
-
Toshiba America Medical Systems, Inc.UnknownConfirm PCA-9000A PET/CT System is Effective for Its Intended UseUnited States
Sponsors and Collaborators
- Institute of Population Research, Peking University
- Michael Zell, MD
- OLVG
- Cook County Health & Hospitals System
- Chin-Tsung Shen
- Momotaro-Gene Inc.
- CARERS TRUST (Carers Trust), UK
- Home care nursing in the Municipality of Esbjerg
- S&T Medical Technologies, Inc.
- Zogenix, Inc.
- West of Scotland Lymphoma Group
- Mrs Hiroko Yuzawa, MD, PhD(c); Department of Intensive Care Medicine, Tokyo, Japan
- Allorion Therapeutics Inc
- YuceBio Technology Co., Ltd.
- King Saud University
- Louisville VA Medical Center
- Common Room Consulting Ltd
- Department of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Romania
- Pak Emirates Military Hospital Rawalpindi
- Barth Wilsey
- View Full List
Medical Conditions
- Caridovascular Disease
- Excitotoxicity
- Granulocyte/ Polymorphonuclear Cells
- Sexual Wellbeing
- Focus of the Study is Satiety
- Peripheral Microvascular Symptoms
- Malalignment, Bone
- Polyneuropathy and Mononeuropathies
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection)
- Degenerative Lumbar Diseases
- Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
- HR+HER2- Breast Cancer
- Antiphospholipid Syndrome
- Locally Advanced or Metastatic Prostate Cancer.
- COPD - Chronic Obstructive Pulmonary Disease
- Platelet-aggregation Inhibitors
- Metastatic or Recurrent Head and Neck Squamous Cell Cancer
- Infant Amino Acid Profile at Day 3 and Discharge
- HODGKIN LYMPHOMA
- Complications, Postoperative
- View Full List
Drug Interventions
- Plerixafor
- Pre-study antiretroviral regimen
- Gardasil
- 120 mg Pseudoephedrine hydrochloride extended release tablets
- Dexmedetomidine injection
- Linagliptin
- PP4001
- 4-Demethyl-4-cholestryloxycarbonylpenclomedine
- HM30181AK 15mg
- Pleyris
- IDX-1197
- Standard care Hyaluronic acid eye drops
- Cohort 2 Probe Substrate
- GSK1247303
- Nilotinib 400 mg BID
- Erenumab Dose 2
- Intensive chemotherapy
- Local medical treatment of raised intraocular pressure
- Pulmozyme
- Lamictal
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Chile
- Contract Research Organizations in Denmark
- Contract Research Organizations in Egypt
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Israel
- Contract Research Organizations in Kenya
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Poland
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Togo
- CRO list by country